title: Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells.
authors.affiliation: Institute of Biomedicine and Molecular Immunology Alberto Monroy, Palermo, Italy.
authors.forename: Antonella
authors.initials: A
authors.lastname: Cusimano
authors.forename: Antonina
authors.initials: A
authors.lastname: Azzolina
authors.forename: Juan L
authors.initials: JL
authors.lastname: Iovanna
authors.forename: Dimcho
authors.initials: D
authors.lastname: Bachvarov
authors.forename: James A
authors.initials: JA
authors.lastname: McCubrey
authors.forename: Natale
authors.initials: N
authors.lastname: D'Alessandro
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Montalto
authors.forename: Melchiorre
authors.initials: M
authors.lastname: Cervello
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D015153:Blotting, Western; D000068579:Celecoxib; D049109:Cell Proliferation / Q000187:drug effects; D052246:Cyclooxygenase 2 Inhibitors / Q000494:pharmacology*; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology*; D004357:Drug Synergism; D005434:Flow Cytometry; D056945:Hep G2 Cells; D006801:Humans; D007976:Leupeptins / Q000494:pharmacology*; D011720:Pyrazoles / Q000494:pharmacology*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D015853:Cysteine Proteinase Inhibitors; D007976:Leupeptins; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib; C072553:benzyloxycarbonylleucyl-leucyl-leucine aldehyde